Concepedia
Statistics
Publications
25
Citations
688
H-Index
17
Active since
2013
Affiliations
University of Chieti-Pescara(Current)
University of L'Aquila
CTI BioPharma (Italy)
Queen Mary University of London
Curtin University
Emily Capone is an author at University of Chieti-Pescara specializing in oncology, molecular oncology, and medicine.
Publications per year
2013–2024
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance
Antonella De Cola, Silvia Volpe, Maria Cristina Budani et al. · Cell Death and Disease · 2015 · 83 citations · Full text
Medicine, Cancer Biology, Oncology +17
HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies
Lucía Gandullo‐Sánchez, Emily Capone, Alberto Ocaña et al. · EMBO Molecular Medicine · 2020 · 55 citations · Full text
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates
Francesco Giansanti, Emily Capone, Sara Ponziani et al. · Journal of Controlled Release · 2018 · 46 citations · Full text
Pharmacy, Cancer Biology, Oncology +17
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma
Emily Capone, Alessia Lamolinara, Daniela D’Agostino et al. · Journal of Controlled Release · 2018 · 38 citations · Full text
Pharmacy, Oncology, Pharmacology +17
Extracellular <scp>LGALS3BP</scp> : a potential disease marker and actionable target for antibody–drug conjugate therapy in glioblastoma
Beatrice Dufrusine, Emily Capone, Sara Ponziani et al. · Molecular Oncology · 2023 · 37 citations · Full text
1–5 of 25